Aura 2016 Supplementary data

Table S4.14 Neisseria gonorrhoeae resistance to ciprofloxacin (MIC ≥1 mg/L), by jurisdiction, 2009–14

Jurisdiction	2009, % of all isolates (n)	2010, % of all isolates (n)	2011, % of all isolates (n)	2012, % of all isolates (n)	2013, % of all isolates (n)	2014, % of all isolates (n)
ACT	5.30 (20)	57.0 (17)	14.0 (9)	34.0 (19)	20.0 (9)	44.0 (33)
NSW	55.0 (525)	40.0 (522)	33.0 (431)	32.0 (539)	35.0 (553)	43.0 (726)
NT: total	2.2 (8)	3.6 (15)	3.5 (16)	2.8 (9)	–	–
NT: urban and rural	na	na	na	na	23.0 (24)	27.0 (27)
NT: remote	na	na	na	na	2.1 (5)	3.1 (4)
Qld	29.0 (163)	27.0 (223)	15.0 (114)	17.0 (120)	29.0 (194)	28.0 (184)
SA	41.0 (70)	59.0 (59)	23.0 (35)	33.0 (49)	26.0 (56)	42.0 (86)
Tas	45.0 (5)	64.0 (7)	40.0 (2)	36.0 (5)	49.0 (22)	27.0 (8)
Vic	59.0 (457)	42.0 (377)	40.0 (374)	46.0 (572)	44.0 (683)	39.0 (559)
WA: total	33.0 (98)	39.0 (128)	21.0 (88)	24.0 (123)	25.0 (123)	–
WA: urban and rural	na	na	na	na	na	30.0 (117)
WA: remote	na	na	na	na	na	5.6 (6)
Australia	43.0 (1346)	34.0 (1348)	26.0 (1069)	30.0 (1436)	34.0 (1669)	36.0 (1750)

– = total for state or territory separated into urban and rural, and remote; ACT = Australian Capital Territory; MIC = minimum inhibitory concentration; na = not available; NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; Vic = Victoria; WA = Western Australia

Source: NNN (Australian Gonococcal Surveillance Programme annual reports)

Table S4.15 Neisseria gonorrhoeae resistance to azithromycin (MIC ≥1 mg/L), by jurisdiction, 2009–14

Jurisdiction	2009, % of all isolates (n)	2010, % of all isolates (n)	2011, % of all isolates (n)	2012, % of all isolates (n)	2013, % of all isolates (n)	2014, % of all isolates (n)
ACT	0.0 (0)	0.0 (0)	6.3 (4)	0.0 (0)	2.2 (1)	9.3 (7)
NSW	0.6 (6)	0.7 (9)	0.3 (4)	0.5 (9)	0.9 (14)	2.0 (33)
NT: total	0.0 (0)	0.0 (0)	0.2 (1)	0.3 (1)	–	–
NT: urban and rural	na	na	na	na	1.0 (1)	0.0 (0)
NT: remote	na	na	na	na	0.0 (0)	0.0 (0)
Qld	2.0 (11)	1.5 (12)	2.7 (21)	2.1 (15)	5.7 (38)	3.5 (23)
SA	4.7 (8)	7.3 (12)	11.0 (16)	0.7 (1)	2.8 (6)	0.5 (1)
Tas	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (0)	3.3 (1)
Vic	na	na	na	2.7 (34)	2.3 (35)	2.3 (33)
WA: total	0.0 (0)	0.6 (2)	0.7 (3)	0.6 (3)	1.9 (9)	–
WA: urban and rural	na	na	na	na	na	5.3 (21)
WA: remote	na	na	na	na	na	0.0 (0)
Australia	1.1 (25)	1.1 (35)	1.5 (49)	1.3 (63)	2.1 (104)	2.5 (119)

– = total for state or territory separated into urban and rural, and remote; ACT = Australian Capital Territory; MIC = minimum inhibitory concentration; na = not available; NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; Vic = Victoria; WA = Western Australia

Source: NNN (Australian Gonococcal Surveillance Programme annual reports)